Analysis of Liquidity Ratios
Quarterly Data
Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
Stryker Corp., liquidity ratios (quarterly data)
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
| Liquidity ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Stryker Corp. current ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022. |
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Stryker Corp. quick ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022. |
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Stryker Corp. cash ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022. |
Current Ratio
Stryker Corp., current ratio calculation (quarterly data)
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Current assets | 8,725) | 10,017) | 9,460) | 9,032) | 8,979) | 9,707) | 13,545) | 12,801) | 10,736) | 11,360) | 8,566) | 8,185) | 7,888) | 9,733) | 7,918) | 7,413) | 7,851) | 7,993) | 7,710) | 8,478) | 7,889) | |||||||
| Current liabilities | 4,408) | 4,549) | 4,449) | 4,252) | 3,953) | 5,041) | 4,689) | 4,405) | 4,162) | 4,400) | 3,921) | 3,946) | 3,713) | 4,807) | 4,153) | 4,046) | 4,800) | 3,485) | 3,258) | 3,552) | 2,554) | |||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||
| Current ratio1 | 1.98 | 2.20 | 2.13 | 2.12 | 2.27 | 1.93 | 2.89 | 2.91 | 2.58 | 2.58 | 2.18 | 2.07 | 2.12 | 2.02 | 1.91 | 1.83 | 1.64 | 2.29 | 2.37 | 2.39 | 3.09 | |||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Current Ratio, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | 1.85 | 1.85 | 1.83 | 1.79 | 1.75 | 1.72 | 1.70 | 1.57 | 1.43 | 1.44 | 1.54 | 1.68 | 1.58 | — | — | — | — | — | — | — | — | |||||||
| Cigna Group | 0.81 | 0.83 | 0.70 | 0.72 | 0.76 | 0.77 | 0.79 | 0.83 | 0.76 | 0.74 | 0.61 | 0.65 | 0.64 | — | — | — | — | — | — | — | — | |||||||
| CVS Health Corp. | 0.88 | 0.88 | 0.94 | 0.95 | 0.93 | 0.91 | 0.95 | 0.98 | 0.99 | 0.94 | 0.92 | 0.95 | 0.95 | — | — | — | — | — | — | — | — | |||||||
| Elevance Health Inc. | 1.36 | 1.47 | 1.48 | 1.49 | 1.57 | 1.55 | 1.59 | 1.64 | 1.53 | 1.65 | 1.70 | 1.64 | 1.61 | — | — | — | — | — | — | — | — | |||||||
| Humana Inc. | 1.53 | 1.62 | 1.72 | 1.71 | 1.67 | 1.77 | 1.81 | 1.69 | 1.66 | 1.82 | 1.83 | 1.75 | 1.65 | — | — | — | — | — | — | — | — | |||||||
| Intuitive Surgical Inc. | 5.22 | 5.08 | 5.58 | 5.99 | 6.71 | 6.86 | 7.04 | 6.38 | 4.96 | 4.53 | 4.64 | 5.04 | 5.44 | — | — | — | — | — | — | — | — | |||||||
| Medtronic PLC | 2.89 | 2.65 | 2.10 | 2.16 | 1.87 | 2.13 | 2.75 | 2.77 | 2.67 | 2.59 | 2.36 | 2.56 | 2.46 | 2.28 | 2.43 | 2.40 | 1.64 | — | — | — | — | |||||||
| Shockwave Medical Inc. | 6.07 | 5.54 | 6.36 | 6.66 | 6.96 | 9.63 | 12.21 | 14.90 | 10.53 | 9.03 | 6.76 | 9.13 | 10.37 | — | — | — | — | — | — | — | — | |||||||
| UnitedHealth Group Inc. | 0.78 | 0.79 | 0.77 | 0.77 | 0.74 | 0.74 | 0.82 | 0.84 | 0.75 | 0.69 | 0.70 | 0.67 | 0.73 | — | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
1 Q1 2022 Calculation
Current ratio = Current assets ÷ Current liabilities
= 8,725 ÷ 4,408 = 1.98
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Stryker Corp. current ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022. |
Quick Ratio
Stryker Corp., quick ratio calculation (quarterly data)
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Cash and cash equivalents | 1,458) | 2,944) | 2,563) | 2,241) | 2,238) | 2,943) | 7,083) | 6,539) | 3,964) | 4,337) | 1,948) | 1,754) | 1,674) | 3,616) | 1,918) | 1,641) | 2,179) | 2,542) | 2,592) | 3,649) | 3,213) | |||||||
| Marketable securities | 72) | 75) | 76) | 84) | 74) | 81) | 78) | 80) | 84) | 88) | 88) | 85) | 84) | 83) | 292) | 279) | 276) | 251) | 97) | 98) | 66) | |||||||
| Accounts receivable, less allowance | 2,991) | 3,022) | 2,817) | 2,714) | 2,616) | 2,701) | 2,426) | 2,203) | 2,646) | 2,893) | 2,438) | 2,408) | 2,284) | 2,332) | 2,076) | 2,089) | 2,108) | 2,198) | 1,965) | 1,905) | 1,875) | |||||||
| Total quick assets | 4,521) | 6,041) | 5,456) | 5,039) | 4,928) | 5,725) | 9,587) | 8,822) | 6,694) | 7,318) | 4,474) | 4,247) | 4,042) | 6,031) | 4,286) | 4,009) | 4,563) | 4,991) | 4,654) | 5,652) | 5,154) | |||||||
| Current liabilities | 4,408) | 4,549) | 4,449) | 4,252) | 3,953) | 5,041) | 4,689) | 4,405) | 4,162) | 4,400) | 3,921) | 3,946) | 3,713) | 4,807) | 4,153) | 4,046) | 4,800) | 3,485) | 3,258) | 3,552) | 2,554) | |||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||
| Quick ratio1 | 1.03 | 1.33 | 1.23 | 1.19 | 1.25 | 1.14 | 2.04 | 2.00 | 1.61 | 1.66 | 1.14 | 1.08 | 1.09 | 1.25 | 1.03 | 0.99 | 0.95 | 1.43 | 1.43 | 1.59 | 2.02 | |||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Quick Ratio, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | 1.21 | 1.28 | 1.25 | 1.19 | 1.16 | 1.14 | 1.01 | 0.93 | 0.83 | 0.88 | 0.93 | 0.98 | 0.94 | — | — | — | — | — | — | — | — | |||||||
| Cigna Group | 0.48 | 0.48 | 0.58 | 0.59 | 0.64 | 0.66 | 0.46 | 0.50 | 0.42 | 0.41 | 0.51 | 0.53 | 0.53 | — | — | — | — | — | — | — | — | |||||||
| CVS Health Corp. | 0.54 | 0.55 | 0.59 | 0.58 | 0.54 | 0.53 | 0.58 | 0.63 | 0.60 | 0.52 | 0.52 | 0.54 | 0.55 | — | — | — | — | — | — | — | — | |||||||
| Elevance Health Inc. | 1.23 | 1.33 | 1.33 | 1.35 | 1.43 | 1.42 | 1.45 | 1.49 | 1.37 | 1.52 | 1.58 | 1.51 | 1.49 | — | — | — | — | — | — | — | — | |||||||
| Humana Inc. | 1.21 | 1.20 | 1.32 | 1.28 | 1.26 | 1.37 | 1.47 | 1.35 | 1.29 | 1.47 | 1.51 | 1.36 | 1.32 | — | — | — | — | — | — | — | — | |||||||
| Intuitive Surgical Inc. | 4.40 | 4.34 | 4.66 | 5.12 | 5.76 | 5.96 | 5.93 | 5.40 | 4.00 | 3.75 | 3.80 | 4.15 | 4.53 | — | — | — | — | — | — | — | — | |||||||
| Medtronic PLC | 2.06 | 1.91 | 1.58 | 1.63 | 1.37 | 1.50 | 2.05 | 2.02 | 1.95 | 1.90 | 1.69 | 1.88 | 1.83 | 1.71 | 1.85 | 1.84 | 1.25 | — | — | — | — | |||||||
| Shockwave Medical Inc. | 4.88 | 4.62 | 5.29 | 5.55 | 5.88 | 8.37 | 10.70 | 13.40 | 9.50 | 8.44 | 6.17 | 8.47 | 9.72 | — | — | — | — | — | — | — | — | |||||||
| UnitedHealth Group Inc. | 0.72 | 0.72 | 0.71 | 0.71 | 0.68 | 0.68 | 0.75 | 0.76 | 0.66 | 0.63 | 0.64 | 0.62 | 0.66 | — | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
1 Q1 2022 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 4,521 ÷ 4,408 = 1.03
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Stryker Corp. quick ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022. |
Cash Ratio
Stryker Corp., cash ratio calculation (quarterly data)
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Cash and cash equivalents | 1,458) | 2,944) | 2,563) | 2,241) | 2,238) | 2,943) | 7,083) | 6,539) | 3,964) | 4,337) | 1,948) | 1,754) | 1,674) | 3,616) | 1,918) | 1,641) | 2,179) | 2,542) | 2,592) | 3,649) | 3,213) | |||||||
| Marketable securities | 72) | 75) | 76) | 84) | 74) | 81) | 78) | 80) | 84) | 88) | 88) | 85) | 84) | 83) | 292) | 279) | 276) | 251) | 97) | 98) | 66) | |||||||
| Total cash assets | 1,530) | 3,019) | 2,639) | 2,325) | 2,312) | 3,024) | 7,161) | 6,619) | 4,048) | 4,425) | 2,036) | 1,839) | 1,758) | 3,699) | 2,210) | 1,920) | 2,455) | 2,793) | 2,689) | 3,747) | 3,279) | |||||||
| Current liabilities | 4,408) | 4,549) | 4,449) | 4,252) | 3,953) | 5,041) | 4,689) | 4,405) | 4,162) | 4,400) | 3,921) | 3,946) | 3,713) | 4,807) | 4,153) | 4,046) | 4,800) | 3,485) | 3,258) | 3,552) | 2,554) | |||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||
| Cash ratio1 | 0.35 | 0.66 | 0.59 | 0.55 | 0.58 | 0.60 | 1.53 | 1.50 | 0.97 | 1.01 | 0.52 | 0.47 | 0.47 | 0.77 | 0.53 | 0.47 | 0.51 | 0.80 | 0.83 | 1.05 | 1.28 | |||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Cash Ratio, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | 0.65 | 0.78 | 0.75 | 0.71 | 0.67 | 0.60 | 0.46 | 0.46 | 0.34 | 0.38 | 0.41 | 0.37 | 0.36 | — | — | — | — | — | — | — | — | |||||||
| Cigna Group | 0.12 | 0.14 | 0.13 | 0.15 | 0.24 | 0.32 | 0.15 | 0.20 | 0.13 | 0.14 | 0.17 | 0.17 | 0.20 | — | — | — | — | — | — | — | — | |||||||
| CVS Health Corp. | 0.16 | 0.18 | 0.20 | 0.17 | 0.15 | 0.18 | 0.19 | 0.27 | 0.21 | 0.15 | 0.14 | 0.17 | 0.16 | — | — | — | — | — | — | — | — | |||||||
| Elevance Health Inc. | 0.86 | 0.95 | 0.97 | 0.97 | 1.08 | 1.04 | 1.04 | 1.10 | 0.95 | 1.08 | 1.14 | 1.07 | 1.04 | — | — | — | — | — | — | — | — | |||||||
| Humana Inc. | 1.02 | 1.08 | 1.20 | 1.12 | 1.12 | 1.29 | 1.39 | 1.22 | 1.16 | 1.37 | 1.44 | 1.28 | 1.15 | — | — | — | — | — | — | — | — | |||||||
| Intuitive Surgical Inc. | 3.58 | 3.66 | 3.98 | 4.42 | 5.04 | 5.30 | 5.27 | 4.85 | 3.44 | 3.13 | 3.11 | 3.37 | 3.79 | — | — | — | — | — | — | — | — | |||||||
| Medtronic PLC | 1.36 | 1.27 | 1.17 | 1.18 | 0.99 | 1.06 | 1.33 | 1.27 | 1.25 | 1.16 | 1.03 | 1.20 | 1.21 | 1.11 | 1.32 | 1.29 | 0.86 | — | — | — | — | |||||||
| Shockwave Medical Inc. | 3.94 | 3.89 | 4.54 | 4.85 | 5.30 | 7.91 | 10.19 | 13.04 | 9.08 | 8.14 | 5.88 | 8.13 | 9.45 | — | — | — | — | — | — | — | — | |||||||
| UnitedHealth Group Inc. | 0.37 | 0.36 | 0.35 | 0.35 | 0.33 | 0.33 | 0.37 | 0.42 | 0.35 | 0.28 | 0.30 | 0.32 | 0.32 | — | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
1 Q1 2022 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 1,530 ÷ 4,408 = 0.35
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Stryker Corp. cash ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022. |